ImpeDx Diagnostics
Leawood
About ImpeDx Diagnostics
ImpeDx Diagnostics is a start-up medical device company founded in 2013, that has secured exclusive rights to develop and market a novel system for rapid detecting bacteria in blood culture specimens for use in clinical laboratories. Their mission is to reduce the mortality rate of septic patients by providing rapid diagnostic products, which will allow clinicians to administer target therapeutic treatments sooner. Their technology compresses blood culture results from days to hours. Not only will rapid identification improve the mortality rate, but it will also have a major impact on healthcare savings.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Last round: Grant (Sep 2018)
- Website: impedx.com
- Phone: (626) 893-2514
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Medical Device
Canonical: https://fsome.com/organization/impedx-diagnostics-178547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.